Evolution of the Average Target: DexCom, Inc.

Evolution of the Target Price: DexCom, Inc.

Changes in Analyst Recommendations: DexCom, Inc.

c2f556fc8a3fc1597216c3f7d5b1c.PEINVIwkuo_x7w2v0IADTAcevZJ1QjHbyfoR_sIysPM.UBBHMspvzdCnrlvbj7VUJWxz3sYqN1Ow8cx-i4Fd_opvF2Ea61Tc16mqfg~85a44ba852e7a395831194493b876476
Aug. 13 Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating MT
Aug. 04 Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating MT
Aug. 03 UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating MT
Aug. 03 Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating MT
Jul. 31 DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says MT
Jul. 31 Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating MT
Jul. 31 RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating MT
Jul. 31 Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating MT
Jul. 31 Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating MT
Jul. 31 Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating MT
Jul. 31 Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating MT
Jul. 31 Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating MT
Jul. 31 Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating MT
Jul. 31 Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating MT
Jul. 31 Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating MT
Jul. 31 JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating MT
Jul. 31 Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating MT
Jul. 31 Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating MT
Jul. 31 Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating MT
Jul. 31 Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating MT
Jul. 31 Jefferies Adjusts Price Target on DexCom to $115 From $112, Maintains Buy Rating MT
Jul. 31 BTIG Adjusts Price Target on DexCom to $90 From $80, Maintains Buy Rating MT
Jul. 31 Raymond James Adjusts Price Target on DexCom to $94 From $91, Maintains Strong Buy Rating MT
Jul. 31 Analyst recommendations: Apple, Baxter International, Dexcom, Flex, Humana, Stellantis… Zonebourse
Jul. 28 UBS Adjusts Price Target on DexCom to $96 From $95, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+2.89%
+7.31%
+8.68%
+20.18%
+15.04%
+6.84%
+25.39%
+16.92%
+17.65%
+11.46%
Average +13.24%
Weighted average by Cap. +11.11%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
91.48USD
Average target price
94.12USD
Spread / Average Target
+2.89%
High Price Target
115.00USD
Spread / Highest target
+25.71%
Low Price Target
79.00USD
Spread / Lowest Target
-13.64%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Citigroup
Argus
UBS
Rothschild & Co Redburn
Leerink Partners
RBC Capital Markets
Wells Fargo Securities
Stifel Nicolaus
Piper Sandler
JPMorgan Chase
Baird
Truist Securities
Deutsche Bank Securities
Bernstein
Benchmark Company
Mizuho Securities
Evercore ISI
Canaccord Genuity
Jefferies & Co.
BTIG
Raymond James
TD Cowen
Goldman Sachs
BofA Securities
Barclays
Morgan Stanley
Wolfe Research
Oppenheimer
Redburn Atlantic
Nephron Research
Cowen
SVB Leerink
Haywood Securities
Berenberg Bank
Guggenheim
Atlantic Equities
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
91.48USD
Average target price
94.12USD
Spread / Average Target
+2.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock
  4. Consensus DexCom, Inc.